157 related articles for article (PubMed ID: 11741474)
21. Development of diversified methods for chemical modification of the 5,6-double bond of uracil derivatives depending on active methylene compounds.
Sajiki H; Iida Y; Ikawa K; Sawama Y; Monguchi Y; Kitade Y; Maki Y; Inoue H; Hirota K
Molecules; 2012 May; 17(6):6519-46. PubMed ID: 22728351
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships of L-dioxolane uracil nucleosides as anti-Epstein Barr virus agents.
Lin JS; Kira T; Gullen E; Choi Y; Qu F; Chu CK; Cheng YC
J Med Chem; 1999 Jun; 42(12):2212-7. PubMed ID: 10377226
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV.
Maruyama T; Demizu Y; Kozai S; Witvrouw M; Pannecouque C; Balzarini J; Snoecks R; Andrei G; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1553-8. PubMed ID: 18066825
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.
Zhang Z; Wallace MB; Feng J; Stafford JA; Skene RJ; Shi L; Lee B; Aertgeerts K; Jennings A; Xu R; Kassel DB; Kaldor SW; Navre M; Webb DR; Gwaltney SL
J Med Chem; 2011 Jan; 54(2):510-24. PubMed ID: 21186796
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
Dolman NP; Troop HM; More JC; Alt A; Knauss JL; Nistico R; Jack S; Morley RM; Bortolotto ZA; Roberts PJ; Bleakman D; Collingridge GL; Jane DE
J Med Chem; 2005 Dec; 48(24):7867-81. PubMed ID: 16302825
[TBL] [Abstract][Full Text] [Related]
27. Antiviral and Cytostatic Evaluation of 5-(1-Halo-2-sulfonylvinyl)- and 5-(2-Furyl)uracil Nucleosides.
Wen Z; Suzol SH; Peng J; Liang Y; Snoeck R; Andrei G; Liekens S; Wnuk SF
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28304114
[TBL] [Abstract][Full Text] [Related]
28. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Danel K; Larsen E; Pedersen EB; Vestergaard BF; Nielsen C
J Med Chem; 1996 Jun; 39(12):2427-31. PubMed ID: 8691437
[TBL] [Abstract][Full Text] [Related]
30. 2-Substituted-4,5-dihydroxypyrimidine-6-carboxamide antiviral targeted libraries.
Boyd VA; Mason J; Hanumesh P; Price J; Russell CJ; Webb TR
J Comb Chem; 2009; 11(6):1100-4. PubMed ID: 19754047
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of various 5-alkoxymethyluracil analogues and structure-cytotoxic activity relationship study.
Brulíková L; Džubák P; Hajdúch M; Hlaváč J
Carbohydr Res; 2011 Oct; 346(14):2136-44. PubMed ID: 21864833
[TBL] [Abstract][Full Text] [Related]
32. Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.
Zhang W; Liu S; Maiga RI; Pelletier J; Brown LE; Wang TT; Porco JA
J Am Chem Soc; 2019 Jan; 141(3):1312-1323. PubMed ID: 30590924
[TBL] [Abstract][Full Text] [Related]
33. An efficient synthesis of a new series of acyclonucleosides starting from beta-amino alcohols.
Agami C; Dechoux L; Hamon L; Melaimi M
J Org Chem; 2000 Oct; 65(20):6666-9. PubMed ID: 11052116
[TBL] [Abstract][Full Text] [Related]
34. A facile synthesis of 5-(perfluoroalkyl)-pyrimidines.
Cech D; Wohlfeil R; Etzold G
Nucleic Acids Res; 1975 Nov; 2(11):2183-92. PubMed ID: 1052538
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
Hirota K; Sawada M; Sajiki H; Sako M
Nucleic Acids Symp Ser; 1997; (37):59-60. PubMed ID: 9585998
[TBL] [Abstract][Full Text] [Related]
36. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
[TBL] [Abstract][Full Text] [Related]
37. Compounds based on 5-(perylen-3-ylethynyl)uracil scaffold: High activity against tick-borne encephalitis virus and non-specific activity against enterovirus A.
Chistov AA; Orlov AA; Streshnev PP; Slesarchuk NA; Aparin IO; Rathi B; Brylev VA; Kutyakov SV; Mikhura IV; Ustinov AV; Westman G; Palyulin VA; Jain N; Osolodkin DI; Kozlovskaya LI; Korshun VA
Eur J Med Chem; 2019 Jun; 171():93-103. PubMed ID: 30909022
[TBL] [Abstract][Full Text] [Related]
38. Simple synthesis of novel acyclic (e)-bromovinyl nucleosides as potential antiviral agents.
Kim JW; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):879-87. PubMed ID: 16901820
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.
Esteban-Gamboa A; Balzarini J; Esnouf R; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
J Med Chem; 2000 Mar; 43(5):971-83. PubMed ID: 10715161
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of some unsaturated 6-azauracil acyclonucleosides.
Kabbaj Y; Lazrek HB; Barascut JL; Imbach JL
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):161-72. PubMed ID: 15892255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
